All In Biotech

Drug Trial Radar · NCT06326060

A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Overweight or Obesity - a Dose Finding Study

Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 354 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

354

Actual

Start

Mar 18, 2024

Primary completion

Apr 10, 2025

Study completion May 1, 2025

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Mar 22, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 different doses of NNC0519-0130. Participants will take 1-2 injections once a week. The study medicine will be injected under skin with a thin needle in the stomach, thigh, or upper arm. The study will last for about 42 weeks.

Conditions

  • Obesity

Interventions

  • NNC0519-0130Drug

    NNC0519-0130 will be administered subcutaneously.

  • PlaceboDrug

    Placebo will be administered subcutaneously.

  • TirzepatideDrug

    Tirzepatide will be administered subcutaneously.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From baseline (week 0) to end of treatment (week 36)

Locations

70 sites in 3 countries. Site status is shown where the registry gives one.

  • Centricity Research-Arizona

    Mesa, Arizona

  • Arkansas Clinical Research

    Little Rock, Arkansas

  • Unity Health-Searcy Medical Center

    Searcy, Arkansas

  • FDRC

    Costa Mesa, California

  • Encompass Clinical Research_Spring Valley

    Spring Valley, California

  • UCLA Health Southbay Endocrine

    Torrance, California

  • Diablo Clinical Research, Inc.

    Walnut Creek, California

  • Univ of Colorado at Denver

    Aurora, Colorado

  • Nature Coast Clinical Research

    Crystal River, Florida

  • Northeast Research Institute

    Fleming Island, Florida

  • Jacksonville Ctr For Clin Res

    Jacksonville, Florida

  • South Broward Research LLC

    Miramar, Florida

  • Cedar-Crosse Research Center

    Chicago, Illinois

  • Midwest Inst For Clin Res

    Indianapolis, Indiana

  • Velocity Clin. Res Valparaiso

    Valparaiso, Indiana

  • L-MARC Research Center

    Louisville, Kentucky

  • Centennial Medical Group

    Columbia, Maryland

  • StudyMetrix Research LLC

    City of Saint Peters, Missouri

  • NYU Bariatric Surgical Ctr

    New York, New York

  • Rochester Clinical Research, Inc.

    Rochester, New York

  • Velocity Clinical Res. Inc Vestal

    Vestal, New York

  • Medication Mgmnt, LLC_Grnsboro

    Greensboro, North Carolina

  • PharmQuest Life Sciences LLC

    Greensboro, North Carolina

  • Physicians East Endocrinology

    Greenville, North Carolina

  • Piedmont Healthcare Statesville

    Statesville, North Carolina

  • Piedmont Healthcare/Research

    Statesville, North Carolina

  • Accellacare

    Wilmington, North Carolina

  • Velocity Clinical Res

    Cleveland, Ohio

  • Remington Davis Inc

    Columbus, Ohio

  • Providence Health Partners Ctr

    Dayton, Ohio

  • Centricity Research - Ohio

    Dublin, Ohio

  • Family Practice Center of Wadsworth Inc.

    Wadsworth, Ohio

  • Lynn Institute of Norman

    Norman, Oklahoma

  • The University of Penn Center

    Philadelphia, Pennsylvania

  • Preferred Primary Care Physicians_Pittsburgh

    Pittsburgh, Pennsylvania

  • Velocity Clin Res Providence

    East Greenwich, Rhode Island

  • Medical University Of South Carolina

    Charleston, South Carolina

  • Spartanburg Medical Research

    Spartanburg, South Carolina

  • Holston Medical Group Pc

    Bristol, Tennessee

  • Baylr Sctt White Rs Inst, Endo

    Dallas, Texas

Showing 40 of 70 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.